Key result
New-onset atrial fibrillation in hemodialysis patients increased ischemic stroke risk, which became insignificant when accounting for competing in-hospital death.
Why the study?
Does new-onset atrial fibrillation increase the risk of ischemic stroke and death in patients undergoing hemodialysis?
Cohort
Yes
Does new-onset atrial fibrillation increase the risk of ischemic stroke and death in patients undergoing hemodialysis?
In hemodialysis patients, new-onset AF is associated with increased mortality, but the apparent increase in ischemic stroke risk is attenuated when accounting for the high competing risk of death, diminishing the predictive value of the CHA2DS2-VASc score.
Answers are grounded in this paper and cite their sources.
Modest stroke risk elevation in HD patients with new AF cautions against routine OAC; leaves open need for RCTs to define net benefit.
BACKGROUND: Whether oral anticoagulant use should be considered in patients undergoing hemodialysis with atrial fibrillation (AF) remains controversial because of the uncertainty regarding risk-benefit assessments. The purpose of this study was to investigate the risk of ischemic stroke in patients undergoing hemodialysis with new-onset AF, in comparison with those without arrhythmia. METHODS AND RESULTS: This nationwide, population-based, propensity score-matched cohort study used data from Taiwan's National Health Insurance Research Database during 1998 to 2011 for patients on hemodialysis with new-onset nonvalvular AF and matched subjects without arrhythmia. The clinical end points were ischemic stroke (fatal or nonfatal), all-cause death, and other serious adverse cardiovascular events. In comparison with the matched cohort, patients with AF (n=6772) had higher risks of ischemic stroke (adjusted hazard ratio [aHR], 1.27; 95% confidence interval [CI], 1.13-1.43), all-cause death (aHR, 1.59; 95% CI, 1.52-1.67), in-hospital cardiovascular death (aHR, 1.83; 95% CI, 1.71-1.94), myocardial infarction (aHR, 1.33; 95% CI, 1.17-1.51), and hospitalization for heart failure (aHR, 1.90; 95% CI, 1.76-2.05). After considering in-hospital death as a competing risk, AF significantly increased the risk of heart failure (HR, 1.56; 95% CI, 1.45-1.68), but not those of ischemic stroke and myocardial infarction. Additionally, the predictive value of the CHA2DS2-VASc score for ischemic stroke was diminished in the competing-risk model. CONCLUSIONS: The risk of stroke was only modestly higher in patients undergoing hemodialysis with new-onset AF than in those without AF, and it became insignificant when accounting for the competing risk of in-hospital death.
No takes yet. Share an insight, caveat, or question.
Shih et al. (2016) conducted a cohort in Hemodialysis with new-onset atrial fibrillation. New-onset nonvalvular atrial fibrillation vs. Matched subjects without arrhythmia was evaluated on Ischemic stroke (fatal or nonfatal) (aHR 1.27, 95% CI 1.13-1.43). New-onset atrial fibrillation in hemodialysis patients increased ischemic stroke risk, which became insignificant when accounting for competing in-hospital death.
Synapse has enriched 10 related papers. Consider them for comparative context: